{"id":"nigetella-salivata","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, there is limited information available on how Nigetella salivata works at a molecular level.","oneSentence":"Nigetella salivata's mechanism of action is not well-documented.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:50:27.052Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT03925714","phase":"PHASE3","title":"Impact of P53 and SIRT1 in Type 2 Diabetes","status":"RECRUITING","sponsor":"Sherief Abd-Elsalam","startDate":"2019-04-01","conditions":"DM","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NS"],"phase":"phase_3","status":"active","brandName":"Nigetella salivata","genericName":"Nigetella salivata","companyName":"Sherief Abd-Elsalam","companyId":"sherief-abd-elsalam","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nigetella salivata is being studied as a potential treatment for type 2 diabetes, alongside Metformin and lifestyle changes, in a clinical trial. The trial, conducted by Tanta University, aims to investigate the impact of Nigetella salivata on the development of type 2 diabetes in prediabetic individuals.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}